US 10653723
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
granted A61KA61K2039/5154A61K2039/5156
Quick answer
US patent 10653723 (Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/5154, A61K2039/5156, A61K2039/5158, A61K2039/55533